Kimberly Chong

Array ( [id] => 10039471 [patent_doc_number] => 09080170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Modified U7 snRNAs for treatment of neuromuscular diseases' [patent_app_type] => utility [patent_app_number] => 13/635356 [patent_app_country] => US [patent_app_date] => 2011-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 10130 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048299 [patent_doc_number] => 20110207625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'PIRNA AND USES RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 13/049367 [patent_app_country] => US [patent_app_date] => 2011-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 41051 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207625.pdf [firstpage_image] =>[orig_patent_app_number] => 13049367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7762815 [patent_doc_number] => 08114985 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-14 [patent_title] => 'Anti-MicroRNA oligonucleotide molecules' [patent_app_type] => utility [patent_app_number] => 13/045685 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11865 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/114/08114985.pdf [firstpage_image] =>[orig_patent_app_number] => 13045685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9020168 [patent_doc_number] => 08530153 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-09-10 [patent_title] => 'Lentiviral transduced dendritic cells for RNAi' [patent_app_type] => utility [patent_app_number] => 13/045297 [patent_app_country] => US [patent_app_date] => 2011-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19465 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13045297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9882779 [patent_doc_number] => 08969544 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'Combined use of PRAME inhibitors and HDAC inhibitors' [patent_app_type] => utility [patent_app_number] => 13/045284 [patent_app_country] => US [patent_app_date] => 2011-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13195 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13045284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10129434 [patent_doc_number] => 09163261 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-20 [patent_title] => 'Adeno-associated virus 2/8—micro RNA-101 therapy for liver cancer' [patent_app_type] => utility [patent_app_number] => 13/580552 [patent_app_country] => US [patent_app_date] => 2011-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 3836 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13580552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696165 [patent_doc_number] => 20110230425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'COMPOSITIONS FOR PROTECTION AND CELLULAR DELIVERY OF INTERFERING RNA' [patent_app_type] => utility [patent_app_number] => 13/032459 [patent_app_country] => US [patent_app_date] => 2011-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3153 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230425.pdf [firstpage_image] =>[orig_patent_app_number] => 13032459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113935 [patent_doc_number] => 20110190376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA' [patent_app_type] => utility [patent_app_number] => 13/031358 [patent_app_country] => US [patent_app_date] => 2011-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12817 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190376.pdf [firstpage_image] =>[orig_patent_app_number] => 13031358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8503219 [patent_doc_number] => 20120302628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'OLIGONUCLEOTIDES WHICH INHIBIT P53 INDUCTION IN RESPONSE TO CELLULAR STRESS' [patent_app_type] => utility [patent_app_number] => 13/575492 [patent_app_country] => US [patent_app_date] => 2011-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 24910 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10621845 [patent_doc_number] => 09340782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-17 [patent_title] => 'Antimir-451 for the treatment of polycythemias' [patent_app_type] => utility [patent_app_number] => 13/574398 [patent_app_country] => US [patent_app_date] => 2011-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10204 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490706 [patent_doc_number] => 20110237654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'METHOD TO INHIBIT CELL GROWTH USING OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 13/008785 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18049 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237654.pdf [firstpage_image] =>[orig_patent_app_number] => 13008785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5973238 [patent_doc_number] => 20110152355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'METHOD FOR PREDICTING AND DETECTING TUMOR METASTASIS' [patent_app_type] => utility [patent_app_number] => 13/006603 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15970 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152355.pdf [firstpage_image] =>[orig_patent_app_number] => 13006603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6003720 [patent_doc_number] => 20110118456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'Interfering RNA Molecules' [patent_app_type] => utility [patent_app_number] => 12/986389 [patent_app_country] => US [patent_app_date] => 2011-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 18948 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118456.pdf [firstpage_image] =>[orig_patent_app_number] => 12986389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10888161 [patent_doc_number] => 08912157 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-16 [patent_title] => 'Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene' [patent_app_type] => utility [patent_app_number] => 13/520496 [patent_app_country] => US [patent_app_date] => 2011-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 30431 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944743 [patent_doc_number] => 20110105363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'siRNA targeting TNFa' [patent_app_type] => utility [patent_app_number] => 12/928950 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 34949 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105363.pdf [firstpage_image] =>[orig_patent_app_number] => 12928950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9552455 [patent_doc_number] => 08759507 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Modulation of exon recognition in pre-mRNA by interfering RNA structure' [patent_app_type] => utility [patent_app_number] => 12/976381 [patent_app_country] => US [patent_app_date] => 2010-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 15533 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12976381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5973213 [patent_doc_number] => 20110152350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Compositions and Methods for Inhibiting Expression of XBP-1 Gene' [patent_app_type] => utility [patent_app_number] => 12/970189 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 53828 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152350.pdf [firstpage_image] =>[orig_patent_app_number] => 12970189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909647 [patent_doc_number] => 08481710 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'RNA interference suppression of neurodegenerative diseases and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/963793 [patent_app_country] => US [patent_app_date] => 2010-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 108 [patent_no_of_words] => 64379 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12963793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178142 [patent_doc_number] => 20110178157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'MODULATION OF HSP47 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/963600 [patent_app_country] => US [patent_app_date] => 2010-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 83466 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178157.pdf [firstpage_image] =>[orig_patent_app_number] => 12963600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9662008 [patent_doc_number] => 08808982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Compositions and methods for reprogramming eukaryotic cells' [patent_app_type] => utility [patent_app_number] => 12/962498 [patent_app_country] => US [patent_app_date] => 2010-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13979 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12962498 [rel_patent_id] =>[rel_patent_doc_number] =>)